Academic Web Pages

Report on our Phase II trial for a HER2 breast cancer vaccine in combination with immune checkpoint inhibition

/by

2022-06-26 00:00:00 - Report on our Phase II trial for a HER2 breast cancer vaccine in combination with immune checkpoint inhibition

| News Observer | Eureka Alert